Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15.5Revenue $M0.1Net Margin (%)-6,155.5Z-Score-2.5
Enterprise Value $M-8.8EPS $-0.7Operating Margin %-6,113.2F-Score4
P/E(ttm))0Cash Flow Per Share $-7.8Pre-tax Margin (%)-6,155.5Higher ROA y-yY
Price/Book0.610-y EBITDA Growth Rate %-5.2Quick Ratio15.2Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-42.9Current Ratio15.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-46.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-59.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M31.0ROI % (ttm)-62.0Gross Margin Increase y-yN

Gurus Latest Trades with APPY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

APPY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


APPY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hurd Donald RSVP & Chief Commercial Officer 2014-04-14Buy35,000$2.04-73.53view
Hurd Donald RSVP, Chief Commerical Officer 2012-09-21Buy15,000$1.99-72.86view
SCHOETTLER GAILDirector 2012-08-03Buy2,500$1.58-65.82view
Lundy StevePresident, CEO 2012-06-29Buy4,000$1.93-72.02view
PUSEY GREGORYVice President 2012-06-29Buy2,000$1.94-72.16view
Merson Michael RDirector 2012-06-29Buy1,000$1.92-71.88view
MCGONEGAL JEFFREYCFO 2012-06-28Buy5,000$1.92-71.88view
Colgin MarkChief Scientific Officer 2009-02-10Sell0$0-71.88view
Merson Michael RDirector 2008-07-01Sell0$0-71.88view

Press Releases about APPY :

    Quarterly/Annual Reports about APPY:

    News about APPY:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Nov 05 2010 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Weekly CFO Buys Highlight: AspenBio Pharma, Solarwinds, Affymetrix, Cascade Financial Corp., Bank of Jul 31 2010 
    advise??? Apr 28 2010 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Nov 05 2009 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Aug 07 2009 
    AspenBio Pharma Inc. (APPY) CEO Daryl Faulkner buys 10,000 Shares May 21 2009 
    AspenBio Pharma Inc. (APPY) COO & Chief Medical Officer Robert Frederick Caspari buys 3,200 Shares May 19 2009 

    More From Other Websites
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Feb 24 2015
    APPY SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Venaxis,... Feb 24 2015
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in... Feb 20 2015
    INVESTOR ALERT: Class Action Lawsuit Against Venaxis, Inc. Announced by Law Offices of Howard G.... Feb 20 2015
    5 Stocks Under $10 Set to Soar: Venaxis, McDermott and More Feb 19 2015
    APPY SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Venaxis,... Feb 18 2015
    INVESTOR ALERT: Class Action Lawsuit Against Venaxis, Inc. Announced By Glancy Binkow & Goldberg LLP Feb 18 2015
    VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 13 2015
    APPY SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Venaxis,... Feb 12 2015
    Venaxis, Receives FDA “Not Substantially Equivalent” Response on APPY1 510(k) Submission Feb 12 2015
    Venaxis Business Update Feb 12 2015
    INVESTOR ALERT: Investigation on Behalf of Investors of Venaxis, Inc. Announced by Law Offices of... Feb 10 2015
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Feb 10 2015
    Law Offices of Marc S. Henzel Announces Securities Class Action Periods Feb 09 2015
    APPY SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Venaxis,... Feb 04 2015
    Robbins Arroyo LLP: Venaxis, Inc. (APPY) Misled Shareholders According to a Recently Filed Class... Feb 03 2015
    INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000... Feb 03 2015
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Feb 03 2015
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Venaxis, Inc.... Feb 02 2015
    INVESTOR ALERT: Investigation of Venaxis, Inc. Announced by Glancy Binkow & Goldberg LLP Jan 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK